New drug HRS-2129 could ease pain after bone surgery
NCT ID NCT06780267
First seen Nov 18, 2025 · Last updated May 24, 2026 · Updated 21 times
Summary
This study is testing a new medicine called HRS-2129 to see if it safely reduces pain after orthopedic surgery (like bone or joint procedures). About 195 adults having planned orthopedic surgery will receive the drug, and researchers will monitor side effects and pain levels over 48 hours. The goal is to find the best dose for effective pain relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN IN ORTHOPAEDICS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sichuan Academy of Medical Sciences - Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, 610072, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.